{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001046","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.080618+00:00","generated_at":"2026-05-19T08:26:22.125173+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Artelo Biosciences completes 1-for-6 reverse stock split; Nasdaq compliance regained","bullets":["Effective 12:01 a.m. ET June 13, 2025; each 6 pre-split shares combine into 1 post-split share; outstanding shares reduced from 3,280,000 to ~546,667.","Authorized common shares reduced from 50M to 8,333,333; preferred authorized reduced from 416,667 to 69,444.","New CUSIP: 04301G607. No fractional shares; holders receive one whole share for any fractional entitlement.","Warrants adjust: each 6 pre-split warrants (exercise $0.75) combine into 1 warrant exercisable at $4.50 per post-split share.","Nasdaq confirmed on June 13, 2025 that ARTL regained compliance with the $1.00 minimum bid price requirement; deficiency matter closed."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001046","json":"https://secwatch.observer/filing/0001640334-25-001046.json","markdown":"https://secwatch.observer/filing/0001640334-25-001046.md","text":"https://secwatch.observer/filing/0001640334-25-001046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001046/0001640334-25-001046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001046/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:26:22.125173+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"036fb3fd1bf394d2746944e295fe569e42073e2e","claim":"ARTELO BIOSCIENCES, INC.: Effected a one-for-six reverse stock split of common stock and proportionally reduced authorized shares (effective 2025-06-13).","evidence_excerpt":"On June 12, 2025, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-six (1-for-6) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001046/0001640334-25-001046-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-13"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}